Terms: = Germ cell tumor AND CIITA, P33076, 4261, ENSG00000179583, MHC2TA, C2TA
52 results:
1. Polycomb repressor complex 2 suppresses interferon-responsive MHC-II expression in melanoma cells and is associated with anti-PD-1 resistance.
James JL; Taylor BC; Axelrod ML; Sun X; Guerin LN; Gonzalez-Ericsson PI; Wang Y; Sanchez V; Fahey CC; Sanders ME; Xu Y; Hodges E; Johnson DB; Balko JM
J Immunother Cancer; 2023 Nov; 11(11):. PubMed ID: 38315170
[TBL] [Abstract] [Full Text] [Related]
2. Engineering human pluripotent stem cell lines to evade xenogeneic transplantation barriers.
Pizzato HA; Alonso-Guallart P; Woods J; Connelly JP; Fehniger TA; Atkinson JP; Pruett-Miller SM; Monsma FJ; Bhattacharya D
Stem Cell Reports; 2024 Feb; 19(2):299-313. PubMed ID: 38215755
[TBL] [Abstract] [Full Text] [Related]
3. Cancer cell plasticity and MHC-II-mediated immune tolerance promote breast cancer metastasis to lymph nodes.
Lei PJ; Pereira ER; Andersson P; Amoozgar Z; Van Wijnbergen JW; O'Melia MJ; Zhou H; Chatterjee S; Ho WW; Posada JM; Kumar AS; Morita S; Menzel L; Chung C; Ergin I; Jones D; Huang P; Beyaz S; Padera TP
J Exp Med; 2023 Sep; 220(9):. PubMed ID: 37341991
[TBL] [Abstract] [Full Text] [Related]
4. Uncoupling CD4+ TIL-Mediated tumor Killing from JAK-Signaling in Melanoma.
Draghi A; Presti M; Jensen AWP; Chamberlain CA; Albieri B; Rasmussen AK; Andersen MH; Crowther MD; Svane IM; Donia M
Clin Cancer Res; 2023 Oct; 29(19):3937-3947. PubMed ID: 37126006
[TBL] [Abstract] [Full Text] [Related]
5. NLRC5-ciita Fusion Protein as an Effective Inducer of MHC-I Expression and Antitumor Immunity.
Santharam MA; Shukla A; Levesque D; Kufer TA; Boisvert FM; Ramanathan S; Ilangumaran S
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108368
[TBL] [Abstract] [Full Text] [Related]
6. ciita-Transduced Glioblastoma cells Uncover a Rich Repertoire of Clinically Relevant tumor-Associated HLA-II Antigens.
Forlani G; Michaux J; Pak H; Huber F; Marie Joseph EL; Ramia E; Stevenson BJ; Linnebacher M; Accolla RS; Bassani-Sternberg M
Mol Cell Proteomics; 2021; 20():100032. PubMed ID: 33592498
[TBL] [Abstract] [Full Text] [Related]
7. RACK7 recognizes H3.3G34R mutation to suppress expression of MHC class II complex components and their delivery pathway in pediatric glioblastoma.
Jiao F; Li Z; He C; Xu W; Yang G; Liu T; Shen H; Cai J; Anastas JN; Mao Y; Yu Y; Lan F; Shi YG; Jones C; Xu Y; Baker SJ; Shi Y; Guo R
Sci Adv; 2020 Jul; 6(29):eaba2113. PubMed ID: 32832624
[TBL] [Abstract] [Full Text] [Related]
8. FoxO1 is a regulator of MHC-II expression and anti-tumor effect of tumor-associated macrophages.
Yang JB; Zhao ZB; Liu QZ; Hu TD; Long J; Yan K; Lian ZX
Oncogene; 2018 Mar; 37(9):1192-1204. PubMed ID: 29238041
[TBL] [Abstract] [Full Text] [Related]
9. Oncogene-Expressing Senescent Melanocytes Up-Regulate MHC Class II, a Candidate Melanoma Suppressor Function.
van Tuyn J; Jaber-Hijazi F; MacKenzie D; Cole JJ; Mann E; Pawlikowski JS; Rai TS; Nelson DM; McBryan T; Ivanov A; Blyth K; Wu H; Milling S; Adams PD
J Invest Dermatol; 2017 Oct; 137(10):2197-2207. PubMed ID: 28647344
[TBL] [Abstract] [Full Text] [Related]
10. Upregulation of HLA Expression in Primary Uveal Melanoma by Infiltrating Leukocytes.
van Essen TH; van Pelt SI; Bronkhorst IH; Versluis M; Némati F; Laurent C; Luyten GP; van Hall T; van den Elsen PJ; van der Velden PA; Decaudin D; Jager MJ
PLoS One; 2016; 11(10):e0164292. PubMed ID: 27764126
[TBL] [Abstract] [Full Text] [Related]
11. Functional disruption of human leukocyte antigen II in human embryonic stem cell.
Chen H; Li Y; Lin X; Cui D; Cui C; Li H; Xiao L
Biol Res; 2015 Oct; 48():59. PubMed ID: 26506955
[TBL] [Abstract] [Full Text] [Related]
12. Exome sequencing of bilateral testicular germ cell tumors suggests independent development lineages.
Brabrand S; Johannessen B; Axcrona U; Kraggerud SM; Berg KG; Bakken AC; Bruun J; Fosså SD; Lothe RA; Lehne G; Skotheim RI
Neoplasia; 2015 Feb; 17(2):167-74. PubMed ID: 25748235
[TBL] [Abstract] [Full Text] [Related]
13. Class II transactivator expression in melanoma cells facilitates T-cell engulfment.
Lloyd MC; Szekeres K; Brown JS; Blanck G
Anticancer Res; 2015 Jan; 35(1):25-9. PubMed ID: 25550531
[TBL] [Abstract] [Full Text] [Related]
14. The N-terminal domain of NLRC5 confers transcriptional activity for MHC class I and II gene expression.
Neerincx A; Jakobshagen K; Utermöhlen O; Büning H; Steimle V; Kufer TA
J Immunol; 2014 Sep; 193(6):3090-100. PubMed ID: 25127861
[TBL] [Abstract] [Full Text] [Related]
15. γ-Interferon-regulated chaperone governs human lymphocyte antigen class II expression.
Kämper N; Franken S; Temme S; Koch S; Bieber T; Koch N
FASEB J; 2012 Jan; 26(1):104-16. PubMed ID: 21940994
[TBL] [Abstract] [Full Text] [Related]
16. Enhancement of HLA class II-restricted CD4+ T cell recognition of human melanoma cells following treatment with bryostatin-1.
Zhao D; Amria S; Hossain A; Sundaram K; Komlosi P; Nagarkatti M; Haque A
Cell Immunol; 2011; 271(2):392-400. PubMed ID: 21903207
[TBL] [Abstract] [Full Text] [Related]
17. Distinct MHC gene expression patterns during progression of melanoma.
Degenhardt Y; Huang J; Greshock J; Horiates G; Nathanson K; Yang X; Herlyn M; Weber B
Genes Chromosomes Cancer; 2010 Feb; 49(2):144-54. PubMed ID: 19862823
[TBL] [Abstract] [Full Text] [Related]
18. Thrombospondin 2 inhibits metastasis of human malignant melanoma through microenvironment-modification in NOD/SCID/gammaCnull (NOG) mice.
Chijiwa T; Abe Y; Ikoma N; Yamazaki H; Tsukamoto H; Suemizu H; Kawai K; Wakui M; Nishime C; Matsumoto H; Matsuyama M; Mukai M; Ueyama Y; Nakamura M
Int J Oncol; 2009 Jan; 34(1):5-13. PubMed ID: 19082472
[TBL] [Abstract] [Full Text] [Related]
19. Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profiling.
Liu S; Ren S; Howell P; Fodstad O; Riker AI
Pigment Cell Melanoma Res; 2008 Oct; 21(5):545-58. PubMed ID: 18627528
[TBL] [Abstract] [Full Text] [Related]
20. A role for EZH2 in silencing of IFN-gamma inducible mhc2ta transcription in uveal melanoma.
Holling TM; Bergevoet MW; Wilson L; Van Eggermond MC; Schooten E; Steenbergen RD; Snijders PJ; Jager MJ; Van den Elsen PJ
J Immunol; 2007 Oct; 179(8):5317-25. PubMed ID: 17911618
[TBL] [Abstract] [Full Text] [Related]
[Next]
